Related Experiment Videos

Kawasaki Disease update

Jane C Burns1

  • 1Department of Pediatrics, UCSD School of Medicine, Rady Children's Hospital, La Jolla, CA 92093, USA. jcburns@ucsd.edu

Indian Journal of Pediatrics
|April 25, 2009
PubMed

Insights

Kawasaki disease is a leading cause of acquired heart disease in children, with unknown causes but significant impacts on the heart. Research is exploring new treatments and genetic factors influencing susceptibility and outcomes.

Area of Science:

  • Pediatric cardiology
  • Immunology
  • Genetics

Background:

  • Kawasaki disease is a growing cause of acquired heart disease in children globally.
  • The exact cause of Kawasaki disease is unknown.
  • It leads to significant arterial wall and myocardial pathology with long-term consequences.

Purpose of the Study:

  • To characterize the pathology and long-term clinical outcomes of Kawasaki disease.
  • To explore novel therapeutic strategies targeting the immune response.
  • To investigate the genetic basis of Kawasaki disease susceptibility and outcomes.

Main Methods:

  • Characterization of arterial wall and myocardial pathology.
  • Long-term clinical follow-up of affected children.
  • Ongoing research into immune response modification and genetic factors.

Main Results:

  • Progress has been made in understanding the pathological features.
  • Long-term clinical consequences are being documented.
  • New treatments and genetic influences are under active investigation.

Conclusions:

  • Kawasaki disease poses a significant threat to pediatric cardiovascular health.
  • Understanding its etiology, pathology, and genetic underpinnings is crucial for developing effective treatments.
  • Further research into immunomodulatory and genetic therapies is warranted.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...